Skip to main content
. Author manuscript; available in PMC: 2017 Oct 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2016 Oct 1;73(2):177–181. doi: 10.1097/QAI.0000000000001027

Figure. Associations of cumulative ARV exposure with urine biomarker levels.

Figure

Bars represent percentage change in biomarker level per year of ARV exposure, with 95% confidence intervals displayed. Estimates are derived from multivariable linear regression models, adjusting for demographics, traditional kidney risk factors, HIV-related factors, and LASSO-selected ARVs. Abbreviations: ABC, abacavir; ACR, albumin-creatinine ratio; ARV, antiretroviral medication; AZT, zidovudine; IL-18, interleukin-18; EFV, efavirenz; LASSO, least absolute shrinkage and selection operator; LPV/r, lopinavir/ritonavir; KIM-1, kidney injury molecule-1; NVP, nevirapine; PIIINP, procollagen type III amino-terminal pro-peptide; TDF, tenofovir disoproxil fumarate.